Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky
2024年6月28日 - 5:45AM
ビジネスワイヤ(英語)
The PPD clinical research business will nearly
double its laboratory footprint in northern Kentucky, add more than
250 jobs
The PPD clinical research business of Thermo Fisher Scientific
Inc., the world leader in serving science, today announced the
expansion of its central laboratory operations in Kentucky
dedicated to accelerating pharmaceutical and biotech customers’
delivery of safe, effective medicines to patients.
The business will expand its sample management and biorepository
operations in a new 65,000-square-foot space in Covington, enabling
further capability expansion at its existing site in nearby
Highland Heights. Thermo Fisher’s $47.8 million investment is
expected to create more than 250 new jobs across the two sites over
the next eight years, with renovation and construction anticipated
to begin later this year.
The PPD clinical research business has operated a central lab
operation in Highland Heights since 2002, and today it includes
central lab services, biomarker operations, sample management and
testing to support new therapeutics, including vaccines and cell
and gene therapy products. The renovation of an existing building
on West 38th Street in Covington will significantly expand the
business’ labs footprint.
“Our central lab plays a vital role in helping our customers
make timely, efficient and informed decisions about their clinical
trials and ensure patient safety,” said Leon Wyszkowski, president,
analytical services, clinical research, Thermo Fisher Scientific.
“Our expansion will enhance their ability to advance life-changing
research. We are excited to expand into Covington and grow our
operations in Highland Heights as a vital part of our global labs
capabilities serving our customers. We value the support of state
and local officials as we continue to hire talented colleagues to
advance our company’s Mission to enable our customers to make the
world healthier, cleaner and safer.”
“The commonwealth is seeing tremendous growth in its health care
and life-sciences sectors, providing high-paying, quality jobs for
Kentucky residents across the state,” said Kentucky Gov. Andy
Beshear. “I am thrilled to see Thermo Fisher once again choose
Kentucky to locate and expand its business. I look forward to the
company’s continued success here in the commonwealth as this
continued investment will be a welcomed addition to the Northern
Kentucky region.”
The Highland Heights central lab, which employs more than 600
analytical laboratory staff, scientific and support professionals,
and Ph.D.-level scientists, offers safety testing including
automated chemistry, urinalysis and hematology, anatomic pathology,
flow cytometry, microbiology and molecular assays. The central lab
also offers a wide variety of other services, such as clinical
sample management, processing and storage, kit design and
preparation for collection of clinical samples, and sample testing
services. The biomarker lab provides support for regulated
biomarkers with immunoassays, flow cytometry and molecular
assays.
In addition to the Highland Heights facility, Thermo Fisher’s
clinical research business has biomarker and central labs in
Brussels, Belgium, and Singapore; bioanalytical, biomarker and
vaccine sciences labs in Richmond, Virginia; bioanalytical and good
manufacturing practices (GMP) labs in Middleton, Wisconsin; a GMP
lab in Athlone, Ireland; and bioanalytical, biomarker, vaccine
sciences and central labs in Suzhou, China.
About Thermo Fisher Scientific Thermo Fisher Scientific
Inc. is the world leader in serving science, with annual revenue
over $40 billion. Our Mission is to enable our customers to make
the world healthier, cleaner and safer. Whether our customers are
accelerating life sciences research, solving complex analytical
challenges, increasing productivity in their laboratories,
improving patient health through diagnostics or the development and
manufacture of life-changing therapies, we are here to support
them. Our global team delivers an unrivaled combination of
innovative technologies, purchasing convenience and pharmaceutical
services through our industry-leading brands, including Thermo
Scientific, Applied Biosystems, Invitrogen, Fisher Scientific,
Unity Lab Services, Patheon and PPD. For more information, please
visit www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240627053298/en/
Media Contact Information: Name: Nadine Maeser Email:
nadine.maeser@ppd.com